A new Botox competitor is coming soon. Here’s how it’s different from other treatments

The FDA just approved a unique botulinum toxin A (BoTX-A) called DAXXIFY™ that lasted an average of six months in research subjects. I performed the research trials that led to … Click to Continue »

View original article